who's going to subscribe?, page-31

Hi Hoyland, not suggesting that, and I think that BLT had little choice but to capital raise and I am happy they have as it gets rid of la Jolla and hopefully the constant manipulation of sp. Just not happy about the non-loyalty to existing holders.

At today's market cap, it's an absolute steal. With funding assurred for the next year or two, BLT suddenly don't seem to be going anywhere soon. If someone was lurking, now would be the best time to go fishing if they want it for a good price.

I think that Alnylam would seriously be looking at BLT. I suspect that they are most likely to be the 'third-party' in the UK patent dispute, as they bought Nucleonics IP and would see BLT as major competition. Their recent legal woes might prevent this however.

Pfizer have also gone very quiet on Tacere's TT-033. They are the one's in the know in regards to the success and potential commercialisation of this drug. Tacere said that the research was going well but now have been left in the dark. Is there something to this? I don't know, but if Pfizer were intended on taking it towards human trials and commercialization, than I very much think that they would be interested in taking out BLT.

All speculation of course.